Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
SABCS 2019
10 - 14 Dec 2019
Henry B. Gonzalez Convention Center, San Antonio, United States of America
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-pos...
Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
23 Jan 2020
Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast c...
Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras
23 Jan 2020
Selective oestrogen receptor degraders as treatment for ER positive/HER2 negativ...
Dr Philippe Aftimos - Institut Jules Bordet, Brussels, Belgium
19 Dec 2019
The challenges of treating breast cancer in Brazil
Dr Felipe Ades - Hospital Alemão Oswaldo Cruz, São Paulo, Brazil
19 Dec 2019
The importance of central pathology pCR review in an international multicenter n...
Dr Hans-Christian Kolberg - Marienhospital, Bottrop, Germany
19 Dec 2019
SABCS 2019 highlights
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
19 Dec 2019
The PEARL study: Palbociclib and endocrine therapy vs capecitabine in HR /HER2- ...
Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain
19 Dec 2019
Imaging for women who are high risk of breast cancer
Dr Maxine Jochelson - Memorial Sloan Kettering Cancer Center, New York City, USA
19 Dec 2019
Adding S-1 to post-operative endocrine therapy in patients with hormone receptor...
Prof Masakazu Toi - Kyoto University, Kyoto, Japan
19 Dec 2019
Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women ...
Dr Terry Mamounas - Orlando Health UF Health Cancer Center, Orlando, USA
19 Dec 2019
KEYNOTE-522: Neoadjuvant pembro chemo vs placebo chemo, followed by adjuvant...
Dr Jay Andersen - Compass Oncology West Cancer Center, Tigard, USA
19 Dec 2019
Residual cancer burden after neoadjuvant therapy and long-term survival outcomes...
Prof William Symmans - MD Anderson Cancer Center, Houston, Texas
19 Dec 2019
Implementation of genetic testing in breast cancer patients
Dr Nadine Tung - Beth Israel Deaconess Medical Center, Boston, USA
19 Dec 2019
Cisplatin versus doxorubicin/cyclophosphamide as neoadjuvant treatment in germli...
Dr Nadine Tung - Beth Israel Deaconess Medical Center, Boston, USA
19 Dec 2019
Breast cancer screening and treatment in Brazil
Dr Gustavo Werutsky - Latin American Cooperative Oncology Group, Porto Alegre, B...
19 Dec 2019
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive b...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
19 Dec 2019
Long-term influence of oestrogen plus progestin vs oestrogen alone on breast can...
Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA
19 Dec 2019
Residual cancer burden after neoadjuvant therapy and long-term survival outcomes...
Prof William Symmans - MD Anderson Cancer Center, Houston, Texas
19 Dec 2019
Circulating tumour DNA used to predict disease recurrence for early triple-negat...
Dr Milan Radovich - Indiana University Melvin and Bren Simon Cancer Center, Indi...
19 Dec 2019
Oral paclitaxel with encequidar in metastatic breast cancer
Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras
19 Dec 2019
Pathologic complete response rates improved with the neoadjuvant and adjuvant tr...
Prof Peter Schmid - St Bartholomew's Hospital London, London, UK
18 Dec 2019
Combining atezolizumab to neoadjuvant chemotherapy does not improve pathologic c...
Dr Luca Gianni - San Raffaele Hospital, Milan, Italy
18 Dec 2019
Breast cancer prevention in high-risk post-menopausal women
Prof Jack Cuzick - Queen Mary University of London, London, UK
18 Dec 2019
Accelerated partial breast irradiation versus whole breast irradiation in patien...
Dr Icro Meattini - Univerity of Florence, Florence, Italy
18 Dec 2019
Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the...
Dr Luca Gianni - San Raffaele Hospital, Milan, Italy
18 Dec 2019
Preventative effects of anastrozole in post-menopausal women who are at high-ris...
Prof Jack Cuzick - Queen Mary University of London, London, UK
18 Dec 2019
How effective is accelerated partial breast irradiation in patients with early b...
Dr Icro Meattini - Univerity of Florence, Florence, Italy
18 Dec 2019
Predicting disease recurrence in patients with early triple-negative breast canc...
Dr Milan Radovich - Indiana University Melvin and Bren Simon Cancer Center, Indi...
18 Dec 2019
The emerging role of immunotherapy for the treatment of early and advanced breas...
Dr Rita Nanda - UChicago Medicine, Chicago, USA
18 Dec 2019
APHINITY: Adding pertuzumab to trastuzumab plus chemotherapy in patients with op...
Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium
18 Dec 2019
Breast cancer incidence in post-menopausal women: Long-term influence of oestrog...
Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA
18 Dec 2019
Could trastuzumab deruxtecan become the new standard of care for pretreated HER2...
Dr Ian Krop - Dana Farber Cancer Institute, Boston, USA
18 Dec 2019
Addition of S-1 to post-operative endocrine therapy for patients with hormone re...
Prof Masakazu Toi - Kyoto University, Kyoto, Japan
18 Dec 2019
Pertuzumab plus trastuzumab and chemotherapy continues to show benefit in HER2-p...
Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium
18 Dec 2019
Trastuzumab deruxtecan yields promising results in HER2-positive breast cancer p...
Dr Ian Krop - Dana Farber Cancer Institute, Boston, USA
18 Dec 2019
KEYNOTE-522 updates: Pembrolizumab plus neoadjuvant chemotherapy in early triple...
Prof Peter Schmid - St Bartholomew's Hospital London, London, UK
18 Dec 2019
